These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 19429701

  • 1. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
    Bimpaki EI, Nesterova M, Stratakis CA.
    Eur J Endocrinol; 2009 Jul; 161(1):153-61. PubMed ID: 19429701
    [Abstract] [Full Text] [Related]

  • 2. Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.
    Almeida MQ, Azevedo MF, Xekouki P, Bimpaki EI, Horvath A, Collins MT, Karaviti LP, Jeha GS, Bhattacharyya N, Cheadle C, Watkins T, Bourdeau I, Nesterova M, Stratakis CA.
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E687-93. PubMed ID: 22259056
    [Abstract] [Full Text] [Related]

  • 3. Targeted Mutational Analysis of Cortisol-Producing Adenomas.
    Rege J, Hoxie J, Liu CJ, Cash MN, Luther JM, Gellert L, Turcu AF, Else T, Giordano TJ, Udager AM, Rainey WE, Nanba K.
    J Clin Endocrinol Metab; 2022 Jan 18; 107(2):e594-e603. PubMed ID: 34534321
    [Abstract] [Full Text] [Related]

  • 4. Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implications.
    London E, Rothenbuhler A, Lodish M, Gourgari E, Keil M, Lyssikatos C, de la Luz Sierra M, Patronas N, Nesterova M, Stratakis CA.
    J Clin Endocrinol Metab; 2014 Feb 18; 99(2):E303-10. PubMed ID: 24248186
    [Abstract] [Full Text] [Related]

  • 5. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
    Tadjine M, Lampron A, Ouadi L, Horvath A, Stratakis CA, Bourdeau I.
    Clin Endocrinol (Oxf); 2008 Sep 18; 69(3):367-73. PubMed ID: 18419788
    [Abstract] [Full Text] [Related]

  • 6. Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.
    Boikos SA, Horvath A, Heyerdahl S, Stein E, Robinson-White A, Bossis I, Bertherat J, Carney JA, Stratakis CA.
    Horm Metab Res; 2008 May 18; 40(5):347-53. PubMed ID: 18491255
    [Abstract] [Full Text] [Related]

  • 7. A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex.
    Horvath A, Giatzakis C, Tsang K, Greene E, Osorio P, Boikos S, Libè R, Patronas Y, Robinson-White A, Remmers E, Bertherat J, Nesterova M, Stratakis CA.
    Eur J Hum Genet; 2008 Oct 18; 16(10):1245-53. PubMed ID: 18431404
    [Abstract] [Full Text] [Related]

  • 8. Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.
    Kool MM, Galac S, Spandauw CG, Kooistra HS, Mol JA.
    J Vet Intern Med; 2013 Oct 18; 27(6):1486-92. PubMed ID: 24112376
    [Abstract] [Full Text] [Related]

  • 9. How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
    Almeida MQ, Stratakis CA.
    Mol Cell Endocrinol; 2011 Apr 10; 336(1-2):162-8. PubMed ID: 21111774
    [Abstract] [Full Text] [Related]

  • 10. New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors.
    Stratakis CA.
    Mol Cell Endocrinol; 2009 Mar 05; 300(1-2):152-7. PubMed ID: 19063937
    [Abstract] [Full Text] [Related]

  • 11. GNAS mutations in adrenal aldosterone-producing adenomas.
    Nakajima Y, Okamura T, Horiguchi K, Gohko T, Miyamoto T, Satoh T, Ozawa A, Ishii S, Yamada E, Hashimoto K, Okada S, Takata D, Horiguchi J, Yamada M.
    Endocr J; 2016 Mar 05; 63(2):199-204. PubMed ID: 26743443
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Genotype-specific cortisol production associated with Cushing's syndrome adenoma with PRKACA mutations.
    Baba R, Oki K, Gomez-Sanchez CE, Otagaki Y, Itcho K, Kobuke K, Kodama T, Nagano G, Ohno H, Yoneda M, Hattori N.
    Mol Cell Endocrinol; 2021 Dec 01; 538():111456. PubMed ID: 34520814
    [Abstract] [Full Text] [Related]

  • 14. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
    Libé R, Mantovani G, Bondioni S, Lania AG, Pedroni C, Beck-Peccoz P, Spada A.
    Exp Clin Endocrinol Diabetes; 2005 May 01; 113(5):248-51. PubMed ID: 15926108
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
    Cazabat L, Ragazzon B, Groussin L, Bertherat J.
    Pituitary; 2006 May 01; 9(3):211-9. PubMed ID: 17036196
    [Abstract] [Full Text] [Related]

  • 18. Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.
    Libé R, Horvath A, Vezzosi D, Fratticci A, Coste J, Perlemoine K, Ragazzon B, Guillaud-Bataille M, Groussin L, Clauser E, Raffin-Sanson ML, Siegel J, Moran J, Drori-Herishanu L, Faucz FR, Lodish M, Nesterova M, Bertagna X, Bertherat J, Stratakis CA.
    J Clin Endocrinol Metab; 2011 Jan 01; 96(1):E208-14. PubMed ID: 21047926
    [Abstract] [Full Text] [Related]

  • 19. cAMP signaling in cortisol-producing adrenal adenoma.
    Calebiro D, Di Dalmazi G, Bathon K, Ronchi CL, Beuschlein F.
    Eur J Endocrinol; 2015 Oct 01; 173(4):M99-106. PubMed ID: 26139209
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.